Related Experiment Video
Updated: Nov 9, 2025

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Phgdh serves a protective role in Il‑1β induced chondrocyte inflammation and oxidative‑stress damage
Hefei Huang1, Keting Liu1, Hua Ou1
1Department of Orthopaedics, Qujing First People's Hospital, Qujing, Yunnan 655000, P.R. China.
Insights
3‑phosphoglycerate dehydrogenase (Phgdh) is reduced in osteoarthritis (OA). Overexpressing Phgdh in chondrocytes protects against OA by promoting extracellular matrix synthesis and reducing inflammation, apoptosis, and oxidative stress.
Area of Science:
- Biochemistry
- Cell Biology
- Pathology
Background:
- Osteoarthritis (OA) is characterized by chondrocyte inflammation and degeneration.
- 3‑phosphoglycerate dehydrogenase (Phgdh) is a key enzyme in serine synthesis, vital for cell growth and metabolism.
- The role of Phgdh in OA chondrocytes remains largely undetermined.
Purpose of the Study:
- To investigate Phgdh expression levels in an OA rat model (in vivo and in vitro).
- To determine the function of Phgdh in chondrocyte extracellular matrix (ECM) synthesis, inflammation, apoptosis, and oxidative stress.
- To explore the regulatory mechanism of Phgdh in chondrocytes.
Main Methods:
- Utilized a rat model of osteoarthritis to assess Phgdh expression.
- Conducted in vitro experiments to evaluate Phgdh's impact on chondrocyte ECM synthesis, inflammatory markers, apoptosis, and oxidative stress.
- Investigated the role of the Keap1/Nrf2 pathway in Phgdh-mediated effects.
Main Results:
- Phgdh expression was found to be decreased in OA.
- Overexpression of Phgdh enhanced ECM synthesis and upregulated antioxidant enzymes (catalase, SOD1).
- Phgdh overexpression reduced inflammatory cytokines (IL-6, TNF-α, ADAMTS5, MMP13), apoptosis, and reactive oxygen species (ROS).
Conclusions:
- Phgdh expression is diminished in osteoarthritis.
- Phgdh plays a protective role in chondrocytes by mitigating inflammation, apoptosis, and oxidative stress.
- Phgdh, potentially regulated by the Keap1/Nrf2 axis, shows therapeutic potential for managing OA progression.
Abstract:
The primary pathological changes observed in osteoarthritis (OA) involve inflammation and degeneration of chondrocytes. 3‑phosphoglycerate dehydrogenase (Phgdh), a rate‑limiting enzyme involved in the conversion of 3‑phosphoglycerate to serine, serves as a crucial molecular component of cell growth and metabolism. However, its effects on chondrocytes in OA have not been determined. In the present study, a rat model of OA was used to investigate the expression levels of Phgdh in vivo and in vitro. Additionally, the role of Phgdh in extracellular matrix (ECM) synthesis, inflammation, apoptosis and oxidative stress levels of chondrocytes was detected in vitro. Phgdh expression was decreased in OA, and Phgdh overexpression promoted ECM synthesis, decreased levels inflammatory cytokines, such as Il‑6, TNF‑α, a disintegrin and metalloproteinase with thrombospondin motifs 5 and MMP13, and decreased apoptosis. Furthermore, expression of Phgdh effectively increased expression levels of the cellular antioxidant enzymes catalase and superoxide dismutase 1, and decreased the levels of reactive oxygen species in chondrocytes; and this may have been regulated by a Kelch like ECH associated protein 1/nuclear factor erythroid 2‑related factor 2 axis. Taken together, these results suggest that Phgdh may be used to manage the progression of OA.
Related Concept Videos
Hedgehog Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
GPCRs Regulate Adenylyl Cylase Activity
TGF - β Signaling Pathway
IP3/DAG Signaling Pathway

